KIDNEY INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2015-09-13 211.97.5.59

再接再厉！JerryChancw 2015-03-02 发表::
研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事

JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事

532 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2020-05-11 Abby2016

现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表::
请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表:
请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？

绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？

236 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

被拒了3次了

258 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

引言怎么写？

113 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2021-12-28 MS68862005

审稿人怎么利用关键词审稿？

120 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2019-09-01 wangqifjz

投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了

243 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2021-06-22 1e1e3459m09(暂无匿称)

偏重的研究方向：肾缺血再灌注损伤
经验分享：第一次投稿KI，记录下，希望能有好运~
① 6-21 22:30左右投稿，状态：
ME:××
PROD：Not Assigned
Awaiting Admin Processing
② 6-22 16:30左右更新状态：
ME：××
ME：××
PROD：Not Assigned
Under Review

205 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2020-04-21 哼哈二将

最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表:
投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了

wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了

225 0

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2020-01-18 12147af7m76(暂无昵称)

后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表::
加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表:
加油

178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油

161 0

[GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？绿色撒哈拉 2020-05-11 00:00:00 发表: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点，投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的，不知道会不会受疫情影响。这个状态是送没送外审呢？我没有推荐审稿人，是不是找不到审稿人？还是编辑觉得没兴趣，还没开始处理？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094560, encodeId=26d41094560c3, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094559, encodeId=f21f1094559ba, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向：肾缺血再灌注损伤 经验分享：第一次投稿KI，记录下，希望能有好运~ ① 6-21 22:30左右投稿，状态： ME:×× PROD：Not Assigned Awaiting Admin Processing ② 6-22 16:30左右更新状态： ME：×× ME：×× PROD：Not Assigned Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589414, encodeId=8e8158941405, content=最后悲剧没有wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=wangqifjz 2019-09-01 00:00:00 发表: 投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583587, encodeId=821858358e8d, content=后来情况怎么样？178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油178qvYs6670(暂无昵称) 2019-09-17 00:00:00 发表: 加油, beContent=178qvYs6670(暂无昵称) 2019-09-17 发表:: 加油, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee32242116, createdName=12147af7m76(暂无昵称), createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581974, encodeId=246e5819e4ca, content=不要气馁！只有不断的精益求精！才会由拒绝到录用的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/24/3ea00e7f8965160bc18125dd2d6bb705.jpg, createdBy=ffd75251480, createdName=18638982816雅雅, createdTime=Sun Dec 22 00:00:00 CST 2019, time=2019-12-22, status=1, ipAttribution=)]

2019-12-22 18638982816雅雅

不要气馁！只有不断的精益求精！才会由拒绝到录用的！

176 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务